Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 1 , Pages 19-27 , March 2009

The optimization of fluorescence imaging of brain tumor tissue differentiated from brain edema—In vivo kinetic study of 5-aminolevulinic acid and talaporfin sodium

  • Takao Tsurubuchi

      Affiliations

    • Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Japan
    • ,
  • Alexander Zoboronok

      Affiliations

    • Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Japan
    • ,
  • Tetsuya Yamamoto, MD, PhD

      Affiliations

    • Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 29 853 3220; fax: +81 29 853 3214.
    • ,
  • Kei Nakai

      Affiliations

    • Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Japan
    • ,
  • Fumiyo Yoshida

      Affiliations

    • Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Japan
    • ,
  • Makoto Shirakawa

      Affiliations

    • 1-1-1 Tennodai, Tsukuba City, Ibaraki Prefecture, #305-8575, Japan
    • ,
  • Masahide Matsuda

      Affiliations

    • Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Japan
    • ,
  • Akira Matsumura

      Affiliations

    • Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Japan

References 

  1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996
  2. Gaspar LE, Fisher BJ, Macdonald DR, et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys. 1992;24(1):55–57
  3. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol. 1999;53(1):53–57
  4. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989;16(6):1405–1409
  5. Albert FK, Forsting M, Sartor K, et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34:45–61
  6. Kowalczuk A, Macdonald RL, Amidei C, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery. 1997;41:1028–1038
  7. Schrieve DC, Alexander EIII, Black PM, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg. 1999;90:72–77
  8. Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol. 1988;6:338–343
  9. Eljamel MS, Good man C, Moseley H. ALA and photofrin(R) fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre phase III randomised controlled trial. Lasers Med Sci. 2008;23:361–367
  10. Moseley H, McLean C, Hockaday S, Eljamel S. In vitro light distributions from intracranial PDT balloons. Photodiag Photodyn Ther. 2007;4:213–220
  11. Eljamel MS. Brain PDD and PDT unlocking the mystery of malignant gliomas. Photodiag Photodyn Ther. 2005;1:303–310
  12. Eljamel MS. Photodynamic assisted surgical resection and treatment of malignant brain tumours technique, technology and clinical application. Photodiag Photodyn Ther. 2004;1:93–98
  13. Eljamel MS. New light on the brain: The role of photosensitising agents and laser light in the management of invasive intracranial tumours. Technol Cancer Res Treat. 2003;2(4):303–309
  14. Kostron H, Bellnier DA, Lin CW, Swartz MR, Maturza RL. Distribution, retention, and phototoxicity of hematoporphyrin derivate in rat glioma: intraneoplastic versus intraperitoneal injection. J Neurosurg. 1986;64:768–774
  15. Lilge L, Wilson BC. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg. 1998;16(2):81–91
  16. Yang VX, Muller PJ, Herman P, Wilson BC. A multispectral fluorescence imaging system: design and initial clinical tests in intra-operative photofrin–photodynamic therapy of brain tumors. Lasers Surg Med. 2003;32(3):224–232
  17. Schmidt MH, Bajic DM, Reichert KW, Martin TS, Meyer GA, Whelan HT. Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery. 1996;38(3):552–557
  18. Stummer W, Stocker S, Novotony A, et al. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B. 1998;45:160–169
  19. Stummer W, Novotny AC, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescene-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93:1003–1013
  20. Kaye AH, Morstyn G, Ashcroft RG. Uptake and retention of hematoporphyrin derivate in an in vivo/vitro models of cerebral glioma. Neurosurgery. 1985;17:883–890
  21. Wise BL, Taxdal DR. Studies of the blood–brain barrier utilizing hematoporphyrin. Brain Res. 1967;4:387–389
  22. Goetz C, Hasan A, Stummer W, Heimann A, Kempski O. Experimental research photodynamic effects in perifocal, oedematous brain tissue. Acta Neurochir (Wien). 2002;144(2):173–179
  23. Kostron H, Fitsch E, Grunert V. Photodynamic therapy of malignant brain tumours: a phase I/II trial. Br J Neurosurg. 1988;2(2):241–248
  24. Stummer W, Gotz C, Hassan A, Heimann A, Kempski O. Kinetics of photofrin II in perifocal brain edema. Neurosurgery. 1993;33:1075–1081
  25. Schmidt MH, Reichert KW, Ozker K, et al. Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors. Pediatr Neurosurg. 1999;30(5):225–231
  26. Hill JS, Kahl SB, Kaye AH, et al. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci U S A. 1992;89(5):1785–1789
  27. Obwegeser A, Jakober R, Kostron H. Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolevulinic acid in the C6 rat glioma model. Br J Cancer. 1998;78:733–738
  28. Regula J, MacTobert AJ, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5-aminolevulinic acid induced protoporphyrin IX—a pilot study. Gut. 1995;36:67–75
  29. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401
  30. Angell-Petersen E, Spetalen S, Madsen SJ, et al. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg. 2006;104(1):109–117
  31. Hirschberg H, Sørensen DR, Angell-Petersen E, et al. Repetitive photodynamic therapy of malignant brain tumors. J Environ Pathol Toxicol Oncol. 2006;25(1-2):261–279
  32. Madsen SJ, Sun CH, Tromberg BJ, Wallace VP, Hirschberg H. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid. Photochem Photobiol. 2000;72:128–134
  33. Miyatake S, Kuroiwa T, Kajimoto Y, Miyashita M, Tanaka H, Tsuji M. Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report. Neurosurgery. 2007;61:1101–1104
  34. Utsuki S, Oka H, Sato S, et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo). 2007;47:210–214
  35. Bothe HE, Bodsch W, Hossmann KA. Relationship between specific gravity, water content, and serum protein extravasation in various types of vasogenic brain edema. Acta Neuropathol (Berl). 1984;64:37–42
  36. Klatzo I, Piraux A, Laskowski EJ. The relationship between edema, blood–brain-barrier and tissue elements in a local brain injury. J Neuropathol Exp Neurol. 1958;17:548–564
  37. Olivo M, Wilson BC. Mapping ALA-induced PpIX fluorescence in normal brain and brain tumour using confocal fluorescence microscopy. Int J Oncol. 2004;5:37–45
  38. van den Boogert JR, Van Hillegersberg FWM, de Rooji RWF, et al. Tilanus 5-aminolevulinic acid-induced protoporphyrin accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B. 1998;44:29–38
  39. Hebeda KM, Saarnak AE, Olivo M, Sterenborg HJCM, Wolbers JG. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir (Wien). 1998;140:503–513
  40. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer. 1993;68(1):41–51
  41. Henderson BW, Vaughan L, Bellnier DA, van Leengoed H, Johnson PG, Oseroff AR. Photosensitization of murine tumor, vasculature and skin by using 5-aminolevulinic acid-induced porphyrin. Photochem Photobiol. 1995;62:780–789
  42. Gomer CJ, Ferrario A. Tissue distribution and photosensitizing properties of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res. 1990;50:3985–3990
  43. Matsumura H, Akimoto J, Haraoka J, Aizawa K. Uptake and retention of photosensitizer mono-l-asparthyl chlorine e6 in experimental malignant glioma. Lasers Med Sci. 2008;23(3):237–245
  44. Long DM. Microvascular changes in cold injury edema. In:  Go KG,  Baethman A editor. Recent progress in the study and therapy of brain edema. New York: Plenum; 1984;p. 45–54
  45. Nag S. FRCPC cold-injury of the cerebral cortex: immunolocalization of cellular proteins and blood–brain barrier permeability studies. J Neuropathol Exp Neurol. 1996;55:880–888
  46. Klatzo I, Wisniewski H, Smith DE. Observations on penetration of serum proteins into the cerebral nervous system. Prog Brain Res. 1965;15:73–88
  47. Reulen HJ, Graham R, Spatz M, Klatzo I. Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosurg. 1977;46:24–35
  48. Friesen SA, Hjortland GO, Madsen SJ, et al. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). Int J Oncol. 2002;21(3):577–582
  49. Novotony A, Xiang J, Stummer W, Teuscher NS, Smith DE, Keep RF. Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem. 2000;75(1):321–328
  50. Wu SM, Ren OG, Zhou MO, Peng Q, Chen JY. Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevuloinic acid and its hexylester. Cancer Lett. 2003;200(2):123–131
  51. Henderson BW, Bellnier DA. Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction. Ciba Found Symp. 1989;146:112–130
  52. Hirschberg H, Spetalen S, Carper S, Hole P, Tillung T, Madsen S. Minimally invasive photodynamic therapy (PDT) for ablation of experimental rat glioma. Minim Invasive Neurosurg. 2006;49(3):135–142
  53. Gaab MR, Poch B, Heller V. Oxygen tension, oxygen metabolism, and microcirculation in vaogenic brain edema. Adv Neurol. 1990;52:247–256
  54. Itabashi Y, Prado GLM, Abo M, Miura H, Abe Y. Dissociation of brain edema induced by cold injury in rat model: MR imaging and perfusion studies with 14C-iodo-antipyrine. Ann Nucl Med. 2001;15(4):337–342

PII: S1572-1000(09)00032-5

doi: 10.1016/j.pdpdt.2009.03.005

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 1 , Pages 19-27 , March 2009

Article Tools

* Image Usage & Resolution